Tizanidine
- Product NDC
- 69420-1504
- 11-digit product format
- 694201504
- Labeler code
- 69420
- Product ID
- 69420-1504_0c48e5d4-3dbb-43f1-ae47-3a34a6f912c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- SA3, LLC
- Application
- ANDA209605
- Marketing category
- ANDA
- Marketing start
- 2018-10-01
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69420-1504-1 | 69420150401 | 150 CAPSULE in 1 BOTTLE (69420-1504-1) | 150 capsule | 2018-10-01 | 0000-00-00 | No | No | Current |